Literature DB >> 7729284

Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent.

K Kusugami1, A Fukatsu, M Tanimoto, M Shinoda, J Haruta, A Kuroiwa, K Ina, K Kanayama, T Ando, T Matsuura.   

Abstract

Local interleukin-6 (IL-6) activity was studied using colonic mucosal tissues in inflammatory bowel disease (IBD) and inflammatory control patients. Active IBD specimens exhibited significantly higher IL-6 activity than control specimens in both cultures of isolated lamina propria mononuclear cells (LPMC) and mucosal tissues with an increased number of IL-6-producing cells. However, the activity in inactive IBD or inflammatory controls did not differ from controls. Northern blot analysis demonstrated IL-6 messenger RNA in LPMC and colonic epithelial cells isolated from active IBD specimens but not in control cells. Furthermore, immunofluorescent microscopic study of active IBD specimens showed more conspicuous staining of IL-6 in infiltrating LPMC (mostly CD68+ cells) and colonic epithelial cells. These results suggest that elevation of local IL-6 activity may be a characteristic feature of active IBD and both macrophages and colonic epithelial cells are the major cell types responsible for this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729284     DOI: 10.1007/bf02064182

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  52 in total

1.  Enhanced mucosal cytokine production in inflammatory bowel disease.

Authors:  W E Pullman; S Elsbury; M Kobayashi; A J Hapel; W F Doe
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

2.  Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease.

Authors:  S Schreiber; R P MacDermott; A Raedler; R Pinnau; M J Bertovich; G S Nash
Journal:  Gastroenterology       Date:  1991-10       Impact factor: 22.682

3.  Immunohistological studies of surface antigen on colonic lymphoid cells in normal and inflamed mucosa. Comparison of follicular and lamina propria lymphocytes.

Authors:  M C Allison; L W Poulter; A P Dhillon; R E Pounder
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

4.  Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls.

Authors:  K Kusugami; K R Youngman; G A West; C Fiocchi
Journal:  Gastroenterology       Date:  1989-07       Impact factor: 22.682

5.  Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine.

Authors:  T T MacDonald; P Hutchings; M Y Choy; S Murch; A Cooke
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

6.  Spontaneous secretion of IgG subclasses by intestinal mononuclear cells: differences between ulcerative colitis, Crohn's disease, and controls.

Authors:  M G Scott; M H Nahm; K Macke; G S Nash; M J Bertovich; R P MacDermott
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

7.  Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease.

Authors:  G Malizia; A Calabrese; M Cottone; M Raimondo; L K Trejdosiewicz; C J Smart; L Oliva; L Pagliaro
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

8.  Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.

Authors:  W S Selby; G Janossy; D Y Mason; D P Jewell
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

Review 9.  Inflammatory mediators in chronic inflammatory bowel diseases.

Authors:  V Gross; T Andus; H G Leser; M Roth; J Schölmerich
Journal:  Klin Wochenschr       Date:  1991-12-15

10.  Colonic mucosal interleukin-6 in inflammatory bowel disease.

Authors:  K Mitsuyama; E Sasaki; A Toyonaga; H Ikeda; O Tsuruta; A Irie; N Arima; T Oriishi; K Harada; K Fujisaki
Journal:  Digestion       Date:  1991       Impact factor: 3.216

View more
  44 in total

1.  Genetic determinants of IL-6 expression levels do not influence bone loss in inflammatory bowel disease.

Authors:  C Schulte; H Goebell; H D Röher; K M Schulte
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

Review 2.  Bone, inflammation, and inflammatory bowel disease.

Authors:  Manasi Agrawal; Shitij Arora; Jianjun Li; Rabin Rahmani; Li Sun; Adam F Steinlauf; Jeffrey I Mechanick; Mone Zaidi
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

Review 3.  Regulation of intestinal epithelial permeability by tight junctions.

Authors:  Takuya Suzuki
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

4.  Type II 11beta-hydroxysteroid dehydrogenase expression in human colonic epithelial cells of inflammatory bowel disease.

Authors:  K I Takahashi; K Fukushima; H Sasano; I Sasaki; S Matsuno; Z S Krozowski; H Nagura
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

5.  Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis.

Authors:  Y Nishio; T Ando; O Maeda; K Ishiguro; O Watanabe; N Ohmiya; Y Niwa; K Kusugami; H Goto
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

6.  Study of the mechanisms of acupuncture and moxibustion treatment for ulcerative colitis rats in view of the gene expression of cytokines.

Authors:  Huan-Gan Wu; Li-Bin Zhou; Ying-Ying Pan; Cheng Huang; Han-Ping Chen; Zheng Shi; Xue-Gui Hua
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

Review 7.  New pathophysiological insights and modern treatment of IBD.

Authors:  Matthias A Engel; Markus F Neurath
Journal:  J Gastroenterol       Date:  2010-03-09       Impact factor: 7.527

8.  Possible involvement of neutrophil elastase in impaired mucosal repair in patients with ulcerative colitis.

Authors:  Yuji Kuno; Kenji Ina; Tsuyoshi Nishiwaki; Tomoyuki Tsuzuki; Masaaki Shimada; Akira Imada; Yuji Nishio; Kazuo Nobata; Takefumi Suzuki; Takafumi Ando; Kenji Hibi; Akimasa Nakao; Tadashi Yokoyama; Yasuhisa Yokoyama; Kazuo Kusugami
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

9.  Implications for a role of interleukin-23 in the pathogenesis of chronic gastritis and of peptic ulcer disease.

Authors:  V Koussoulas; S Vassiliou; E J Giamarellos-Bourboulis; G Tassias; A Kotsaki; C Barbatzas; M Tzivras
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

10.  Food allergy alters jejunal circular muscle contractility and induces local inflammatory cytokine expression in a mouse model.

Authors:  Jørgen Valeur; Jani Lappalainen; Hannu Rita; Aung Htun Lin; Petri T Kovanen; Arnold Berstad; Kari K Eklund; Kirsi Vaali
Journal:  BMC Gastroenterol       Date:  2009-05-18       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.